Application — Cortical surface
Mindtrix cortical visual reconstruction first human study (2025)
Lab or organization
Mindtrix cortical visual reconstruction first human study (2025)
The first reported human study for Mindtrix’s cortical visual reconstruction system, announced in December 2025. Sources are Chinese-language press and the company; no registry record or peer-reviewed paper was found, so claims are labeled by source.
Study facts
| Field | Value and source scope |
|---|---|
| Study type | Investigator-initiated trial (IIT), per the founder’s statement to China Science Daily [1] |
| Participant | One patient with occipital lobe epilepsy who already had temporary therapeutic electrodes placed for surgery; the stimulation study ran in the window after that implant. The patient was not fully blind and had a largely intact visual pathway [1] |
| Hardware used | Temporary clinical electrodes from the epilepsy workup, not the company’s own implant; whether the company’s ECOG-RS array was involved is not stated [1] |
| First reported result | The patient reported colored points and simple shapes when the visual cortex was stimulated with the eyes covered (China Science Daily, December 22, 2025) [1]. The company’s announcement of a “global first” quantitative perception of complex shapes and colors was reported by Science and Technology Daily on December 5, 2025 [3] |
| Second reported result | In February 2026 the company announced a “world’s first” grayscale visual reconstruction: subjects identified numbers and simple geometric shapes (company statement carried by VCBeat) [5] |
| Team | Founder Liu Bing, associate researcher at the Chinese Academy of Sciences Institute of Automation; company founded 2024 [1] |
| Status and plans | IIT stage. The founder said the team plans registration type testing in 2026 and a registration trial for blind patients in 2028 [1]. VCBeat reported (May 31, 2026) a planned IIT in totally blind patients [6]; chief marketing officer Chen Wenkai gave 2026 goals of 4 to 8 fully blind IIT participants and a market target around 2030 to 2031 [7][8]. No regulatory approval |
| Registry or paper | None found in ClinicalTrials.gov (searched October 25, 2026) or peer-reviewed indexes; no ChiCTR record surfaced in search |
Limits
All human-result claims are company statements carried by Chinese press; the patient count is one, the hardware was not the product implant, and no data tables are published. Product claims for the intended system (glasses, VPU, RV-IPG stimulator, cortical array) stay on the device sheet.
Primary sources
- China Science Daily via CAS (Chinese). Climbing the BCI ‘Everest’, 22 December 2025. Verified October 25, 2026.
- Mindtrix company site (Chinese). Technology and products.
- Science and Technology Daily (Chinese). Seven BCI products launched in Shanghai, 5 December 2025.
- Guangzhou Daily (Chinese). BCI conference report, December 2025.
- VCBeat, first grayscale visual reconstruction report, 2026. Company announcement coverage.
- VCBeat, Mindtrix to launch IIT trial in totally blind patients, May 31, 2026.
- X-techcon interview with Chen Wenkai, 2026 (Chinese).
- China Daily, Mindtrix market-entry interview, July 9, 2026.